Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $156.38 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $77.92 | 4 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $23.38 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.11 | 1 | $0 (2017) |
| Lilly USA, LLC | $13.63 | 1 | $0 (2017) |
| PFIZER INC. | $11.83 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $10.51 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $156.38 | 10 | GlaxoSmithKline, LLC. ($77.92) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/06/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2017 | Janssen Pharmaceuticals, Inc | INVOKAMET (Drug), XARELTO, INVOKANA | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2017 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: VACCINES | ||||||
| 08/25/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/25/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET, XARELTO | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 02/24/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: RESPIRATORY | ||||||
About Dr. Mark Clarkson, D.O
Dr. Mark Clarkson, D.O is a Family Medicine healthcare provider based in Peterstown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508886987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Clarkson, D.O has received a total of $156.38 in payments from pharmaceutical and medical device companies, with $156.38 received in 2017. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($156.38).
Practice Information
- Specialty Family Medicine
- Location Peterstown, WV
- Active Since 07/20/2006
- Last Updated 11/18/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1508886987
Products in Payments
- BREO (Drug) $62.09
- STIOLTO (Drug) $19.11
- ANORO (Drug) $15.83
- TRULICITY (Drug) $13.63
- INVOKAMET (Drug) $12.33
- PREVNAR - 13 (Biological) $11.83
- INVOKANA (Drug) $11.05
- FARXIGA (Drug) $10.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.